TRAIL R1/DR4/TNFRSF10A[Biotin], His & Avi, Human
¥5800 | |
Z04632-100 | |
|
|
|
|
|
¥5800 | |
Z04632-100 | |
|
|
|
|
|
Species | Human | ||||||
Protein Construction |
|
||||||
Conjugate | Biotin | ||||||
Purity | > 95% as determined by BisTris PAGE | ||||||
Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||||
Expression System | HEK293 | ||||||
Theoretical Molecular Weight | 24.7 kDa | ||||||
Apparent Molecular Weight | Due to glycosylation, the protein migrates to 25-30 kDa based on Bis-Tris PAGE result. | ||||||
Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||||
Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized Human Trail, No Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for TRAIL R1/DR4/TNFRSF10A[Biotin], His & Avi, Human, His Tag with the EC50 of 0.38 μg/ml determined by ELISA. »
The purity of TRAIL R1/DR4/TNFRSF10A[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC. »
TRAIL R1/DR4/TNFRSF10A[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%. »
TRAIL R1/DR4/TNFRSF10A[Biotin], His & Avi, Human, His-Avi Tag immobilized on CM5 Chip can bind Human TRAIL, No Tag with an affinity constant of 0.315 nM as determined in SPR assay (Biacore T200). »
Target Background | Tumor necrosis factor receptor superfamily member 10A (TNFRSF10A) is also known as TNF-related apoptosis-inducing ligand receptor 1 (TRAIL-R1), Death receptor 4 (DR4), CD261 and APO2, which belongs to TNF superfamily.The expression of apoptosis-inducing TRAIL-R1 and TRAIL-R2 and of the decoy receptors TRAIL-R3 and TRAIL-R4 was systematically studied in all developmental stages of peripheral B cells isolated from the blood and secondary lymphoid organs. Expression of TRAIL-Rs is modulated along development, with highest levels observed in germinal center B cells. |
Synonyms | DR4; CD261; TNFRSF10A; TRAIL-R; APO2; TRAIL R1; MGC9365 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.